Erin Glynn Tranont Appointment Strengthens Women’s Wellness Leadership
Tranont proudly announces the newest member of its Scientific Advisory Board, Dr. Erin Glynn—a leading expert in metabolic health, nutrition science, and product innovation, with over 20 years of combined experience in academia and the nutraceutical industry.
This appointment reinforces Tranont’s dedication to women’s wellness and adds significant strength to its science-backed approach to developing holistic health solutions.
In her role on the Scientific Advisory Board, Dr. Erin Glynn will collaborate with Tranont’s executive and product teams to lead scientific innovation, oversee wellness product development, and contribute to the company’s educational initiatives.
With a strong passion for simplifying complex science, Dr. Glynn aims to equip Tranont’s field leaders with powerful tools and training that make communicating product benefits easier and more impactful.
“I’m thrilled and honored to join the Tranont family as part of the Scientific Advisory Board,” said Dr. Glynn.
“What truly drew me to Tranont was the company’s uniqueness, quality formulations, and mission to impact 1 billion lives for good.”
She specifically cited products like DHS, Tranont For Her, and the new Creatine formula as powerful examples of Tranont’s science-first approach to wellness.
Glynn’s appointment also signals Tranont’s commitment to representation in women’s health and advancing clinical research in underserved areas. Her new role will include public-facing responsibilities—helping shape the company’s narrative on simplifying wellness through effective, research-based products that fit into everyday life.
Dr. Glynn holds a bachelor’s degree in exercise physiology from Texas A&M University and a doctorate in preventive medicine and community health from the University of Texas Medical Branch. She further expanded her expertise through a postdoctoral fellowship at Duke University’s Stedman Nutrition & Metabolism Center, focusing on metabolic research and clinical application.
Over her career, she has authored more than 30 peer-reviewed research publications and presented at top scientific conferences across the U.S.
Following over a decade in academic research, Dr. Glynn transitioned into the dietary supplement industry, where she led R&D for multimillion-dollar wellness brands. Her approach merges data-driven science with real-world wellness education.
“Dr. Glynn’s expertise in metabolic and gut health will be instrumental in driving future product innovations,” said Russell Losee, Co-Founder and COO of Tranont.
“Her holistic approach aligns perfectly with Tranont’s commitment to life-changing health products and associate empowerment.”
Tranont delivers wellness and lifestyle solutions through a direct selling model, offering research-backed supplements and community-driven business opportunities.
The company’s mission is to make wellness accessible and achievable through clinically validated ingredients, education, and simple, daily-use solutions. Its Scientific Advisory Board, now strengthened by Dr. Erin Glynn, ensures that innovation and credibility remain central to every product developed.
Tranont continues to lead a movement focused on improving women’s health, creating generational wealth, and fostering meaningful community transformation.
To learn more about Tranont’s wellness mission and scientific vision, visit tranont.com.
There are no reviews yet. Be the first one to write one.
